Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma

Pathology International

Volumn 59, Issue 4, 2009, Pages 229-233

  Bologna Molina, Ronell ^a,b,c   Mosqueda Taylor, Adalberto ^d   Lopez Corella, Eduardo ^e   De Almeida, Oslei Paes ^f   Carrasco Daza, Daniel ^e   Farfán Morales, José E ^e   Molina Frechero, Nelly ^d   Damián Matsumura, Pablo ^g  

^a Universidad Autónoma ^*  (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

^d DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^e INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^f UNIVERSITY OF CAMPINAS   (Brazil)

^g DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

Ameloblastic carcinoma; CD138; Desmoplastic ameloblastoma; Ki 67; Peripheral ameloblastoma; Syndecan 1

Indexed keywords

KI 67 ANTIGEN; SYNDECAN 1;

AMELOBLASTIC CARCINOMA; AMELOBLASTOMA; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CARCINOMA; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DESMOPLASTIC AMELOBLASTOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMELOBLASTOMA; CARCINOMA; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; KI-67 ANTIGEN; PROGNOSIS; SYNDECAN-1;

EID: 63849234509     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02355.x     Document Type: Article

References (36)

1. Barnes L, Eveson JW, Reichart P, Sidransky D (eds) World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon : IARC Press, 2005.
2. Ledesma C, Mosqueda-Taylor A, Carlos-Bregni R et al. Ameloblastomas: A regional Latin-American multicentric study. Oral Dis 2007 13 : 303 7.
3. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E et al. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol 2008 44 : 805 11.
4. Sivapathasundharam B, Einstein A, Syed Rafiuddeen I. Desmoplastic ameloblastoma in Indians. Report of five cases and review of the literature. Indian J Dent Res 2007 18 : 218 21.
5. Lin SC, Lieu CM, Hahn LJ, Kwan HW. Peripheral ameloblastoma with metastasis. Int J Oral Maxillofac Surg 1987 16 : 202 6.
6. Philipsen HP, Reichart P, Nikai H, Takata T, Kudo Y. Peripheral ameloblastoma: Biological profile based on 160 cases from the literature. Oral Oncol 2001 37 : 17 27.
7. Ruoshanti E. Proteoglycans in cell regulation. J Biol Chem 1989 264 : 13369 72.
8. Sanderson RD, Hinkes MT, Bernfield M. Syndecan-1, a cell surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 1992 66 : 314 23.
9. Inki P, Larjava H, Haapasalmi K, Miettinen HM, Grenman R, Jalkanen M. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur J Cell Biol 1994 63 : 43 51.
10. Anttonen A, Kajanti M, Heikkila P, Jalkanen M, Joensuu H. Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer 1999 79 : 558 64.
11. Joensuu H, Anttonen A, Eriksson M et al. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 2002 62 : 5210 17.
12. Zellweger T, Nink C, Mirlacher M et al. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate 2003 55 : 20 29.
13. Shah L, Walter K, Borczuk A, Kawut S, Sonett J, Gorestein L. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with non small cell lung carcinoma. Cancer 2004 101 : 1632 8.
14. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Takamori K. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous carcinoma. J Oral Pathol Med 2006 35 : 301 6.
15. Gurol M, Burkes EJ Jr. Peripheral ameloblastoma. J Periodontol 1995 66 : 1065 8.
16. El-Mofty SK, Gerard NO, Farsi SE, Rodu B. Peripheral ameloblastoma: A clinical and histologic study of 11 cases. J Oral Maxillofac Surg 1991 49 : 970 76.
17. Philipsen HP, Reichart PA, Takata T. Desmoplastic ameloblastoma (including 'hybrid' lesion of ameloblastoma). Biological profile based in 100 cases from the literature and own files. Oral Oncol 2001 37 : 455 60.
18. Slootweg PJ, Müller H. Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol 1984 57 : 168 79.
19. Benlyazid A, Lacroix-Triki M, Aziza R, Gomez-Brouchet A, Guichard M, Sarini J. Ameloblastic carcinoma of the maxilla: Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 104 : e17 24.
20. Koda J, Rapraeger A, Bernfield M. Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens. J Biol Chem 1985 260 : 4870 77.
21. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999 68 : 729 77.
22. Saunders S, Bernfield M. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor on interstitial matrix. J Cell Biol 1988 106 : 423 30.
23. Salmavirta M, Elenius K, Vainio S et al. Syndecan from embryonic tooth mesenquime binds tenascin. J Biol Chem 1991 266 : 7733 39.
24. Salmavirta M, Rauvala H, Elenius K, Jalkanen M. Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res 1992 200 : 444 51.
25. Salmavirta M, Mali M, Heino H, Hermonen J, Jalkanen M. A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells. Exp Cell Res 1994 215 : 180 88.
26. Elenius K, Määttä A, Salmavirta M, Jalkanen M. Growth factors induce 3T3 cells to express bFGF-binding. J Biol Chem 1992 25 : 6435 41.
27. Hayashi K, Hayashi M, Jalkanen M, Firestone JH, Trelstad RL, Bernfield M. Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissue. A light and electron microscopic study. J Histochem Cytochem 1987 35 : 1079 88.
28. Thesleff I, Jalkanen M, Vainio S, Bernfield M. Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis. Dev Biol 1988 129 : 565 72.
29. Vainio S, Lehtonen E, Jalkanen M, Bernfield M, Saxen L. Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol 1989 134 : 382 91.
30. Vainio S, Jalkanen M, Thesleff I. Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme. J Cell Biol 1989 108 : 1945 54.
31. David G, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992 118 : 961 69.
32. David G, Bai XM, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development 1993 119 : 841 54.
33. Leocata P, Villari D, Fazzari C, Lentini M, Fortunato C, Nicotina PA. Syndecan-1 and Wingless-type protein-1 in human ameloblastomas. J Oral Pathol Med 2007 36 : 394 9.
34. Ro Y, Muramatsu T, Shima K et al. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue. Int J Oral Maxillofac Surg 2006 35 : 252 7.
35. Tulumori V, Thomas GA, Fraser IS. The relationship of proliferating cell density at the invasive tumor front with prognostic and risk factors in human oral squamous cell carcinoma. J Oral Pathol Med 2004 33 : 204 8.
36. Kim J, Yook JI. Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas. Eur J Cancer B Oral Oncol 1994 30B : 126 31.